TNXP TONIX PHARMACEUTICALS HOLDING
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 6 analyst firms say about TONIX PHARMACEUTICALS HOLDING: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 4 reports on TNXP from 4 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Alliance Global Partners | James Molloy | Buy | 28 Sep 2026 | 65.00 USD |
| Canaccord Genuity | Gary Nachman | Buy | 26 Oct 2026 | 18.00 USD |
| Noble Capital Markets | Robert Leboyer | Buy | 17 Dec 2025 | 34.00 USD |
| Raymond James | Tiago Fauth | Buy | 20 Oct 2026 | — |
| TD Cowen | Stacy Ku | Buy | 5 May 2026 | 22.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:51 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.